Drugs / DF1001
last change Dec 2025 re-read 2 minutes ago

DF1001

Developed for
cancer
Investigated by
Dragonfly Therapeutics

Trials 1 · a red edge is where a trial was stopped

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT04143711 Nov 2019 → Dec 2025 cancer Dragonfly Therapeutics Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DF1001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04143711